Inventor · disambiguated record
David Buckler
Also filed as: BUCKLER DAVID · BUCKLER DAVID R · BUCKLER DAVID ROGERS
18 granted patents·25 pending applications·290 citations·filing 1995–2025
95Inventor score
Files withREGENERON PHARMA14ACCELERON PHARMA INC7MERRIMACK PHARMACEUTICALS INC5APPLIED RESEARCH SYSTEMS4SCHOEBERL BIRGIT3
Top patents by PatentIndex Score
43 records- 0198US7846440B2Antibodies against ErbB3 and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2008·Granted Dec 7, 2010·92 cites·18 claims
- 0296US10143186B2Common light chain mouseMCWHIRTER JOHN·Filed 2011·Granted Dec 4, 2018·34 cites·28 claims
- 0394US8961966B2Antibodies against ERBB3 and uses thereofSCHOEBERL BIRGIT·Filed 2010·Granted Feb 24, 2015·20 cites·15 claims
- 0494US8691225B2Antibodies against the ectodomain of ErbB3 and uses thereofSCHOEBERL BIRGIT·Filed 2009·Granted Apr 8, 2014·26 cites·20 claims
- 0590US2024360243A1Antibodies against the ectodomain of erbb3 and uses thereofELEVATION ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 0690US2025066488A1Actriib binding agents and uses thereofACCELERON PHARMA INC·Filed 2024·Application pending·0 cites
- 0788US8765385B2Method of detection of neutralizing anti-actriib antibodiesKUMAR RAVINDRA·Filed 2011·Granted Jul 1, 2014·15 cites·8 claims
- 0888US8008445B2Metalloproteinase 9 binding proteinsDYAX CORP·Filed 2009·Granted Aug 30, 2011·11 cites·4 claims
- 0987US6653338B2FSH mimetics for the treatment of infertilityAPPLIED RESEARCH SYSTEMS·Filed 2002·Granted Nov 25, 2003·33 cites·5 claims
- 1085US9624301B2Polynucleotides encoding an actriib antibodyACCELERON PHARMA INC·Filed 2016·Granted Apr 18, 2017·3 cites·4 claims
- 1185US9487588B2Antibodies against the ectodomain of ERBB3 and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2014·Granted Nov 8, 2016·4 cites·4 claims
- 1283US10986820B2Common light chain mouseREGENERON PHARMA·Filed 2018·Granted Apr 27, 2021·1 cites·25 claims
- 1382US10259870B2Anti-ANGPTL8 antibodies and uses thereofREGENERON PHARMA·Filed 2016·Granted Apr 16, 2019·2 cites·3 claims
- 1482US2025386809A1Common light chain mouseREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1582US2024156070A1Common light chain mouseREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1681US6423723B1FSH mimetics for the treatment of infertilityAPPLIED RESEARCH SYSTEMS·Filed 2000·Granted Jul 23, 2002·19 cites·9 claims
- 1779US2022204642A1Antibodies against the ectodomain of erbb3 and uses thereofELEVATION ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 1876US2022098309A1Actriib binding agents and uses thereofACCELERON PHARMA INC·Filed 2021·Application pending·0 cites
- 1976US2021204531A1Common light chain mouseREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 2073US8455205B2Metalloproteinase 9 binding proteinsDEVY LAETITIA·Filed 2011·Granted Jun 4, 2013·2 cites·16 claims
- 2169US2010056761A1Antibodies against erbb3 and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2269US2019292271A1Antibodies against the ectodomain of erbb3 and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2367US8034898B2Methods of collagen imagingCOLLAGEN MEDICAL LLC·Filed 2006·Granted Oct 11, 2011·8 cites·17 claims
- 2467US2019090462A1Common light chain mouseREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 2567US2019021295A1Common light chain mouseREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 2666US2013302836A1Common light chain mouseREGENERON PHARMA·Filed 2013·Application pending·0 cites
- 2766US2019023797A1Actriib binding agents and uses thereofACCELERON PHARMA INC·Filed 2018·Application pending·0 cites
- 2865US2015030606A1Actriib binding agents and uses thereofACCELERON PHARMA INC·Filed 2014·Application pending·0 cites
- 2963US2017073427A1Antibodies against the ectodomain of erbb3 and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3062US2018051088A1Actriib binding agents and uses thereofACCELERON PHARMA INC·Filed 2017·Application pending·0 cites
- 3162US2012192300A1Common Light Chain MouseBABB ROBERT·Filed 2012·Application pending·0 cites
- 3261US2013189269A1Actriib binding agents and uses thereofACCELERON PHARMA INC·Filed 2013·Application pending·0 cites
- 3359US2013185821A1Common Light Chain MouseREGENERON PHARMA·Filed 2013·Application pending·0 cites
- 3457US2013045492A1Methods For Making Fully Human Bispecific Antibodies Using A Common Light ChainREGENERON PHARMA·Filed 2012·Application pending·0 cites
- 3554US6235755B1FSH mimetics for the treatment of infertilityAPPLIED RESEARCH SYSTEMS·Filed 1999·Granted May 22, 2001·10 cites·8 claims
- 3654US6033903AMethod of expressing and secreting soluble extracellular domains of human gonadotropin hormone receptorsAPPLIED RESEARCH SYSTEMS·Filed 1995·Granted Mar 7, 2000·9 cites·14 claims
- 3754US2022409732A1Peptide-mhc ii protein constructs and uses thereofREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 3852US9386938B2Methods for collagen imagingCARAVAN PETER D·Filed 2011·Granted Jul 12, 2016·1 cites·18 claims
- 3952US2012021409A1Common Light Chain MouseMCWHIRTER JOHN·Filed 2011·Application pending·0 cites
- 4050US2012244163A1Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereofSCHOEBERL BIRGIT·Filed 2012·Application pending·0 cites
- 4148US2015313193A1Common Light Chain MouseREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 4238US2017058045A1Methods, compositions and kits for cell specific modulation of target antigensREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 4332US10519240B2Anti-FGFR1c antibody-FGF21 fusion proteinsREGENERON PHARMA·Filed 2015·Granted Dec 31, 2019·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →